GGrantIndex
Sort

261,768 grants matching gene therapy

Randomized trial of universal vs. guideline-directed germline testing among young adults with cancer

$4,815,109
Katherine L Nathanson · University Of Pennsylvania · U01 · FY2019 · CA

Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors.

$4,810,822
Arzu Onar-Thomas · St. Jude Children'S Research Hospital · UM1 · FY2020 · CA

CRISPR for Cure

$4,807,696
Kamel Khalili · Temple Univ Of The Commonwealth · UM1 · FY2023 · AI

CRISPR for Cure

$4,807,696
Kamel Khalili · Temple Univ Of The Commonwealth · UM1 · FY2021 · AI

CRISPR for Cure

$4,807,696
Kamel Khalili · Temple Univ Of The Commonwealth · UM1 · FY2024 · AI

CRISPR for Cure

$4,807,696
Kamel Khalili · Temple Univ Of The Commonwealth · UM1 · FY2025 · AI

CRISPR for Cure

$4,807,696
Kamel Khalili · Temple Univ Of The Commonwealth · UM1 · FY2022 · AI

Center for the Structural Biology of Cellular Host Elements in Egress, Trafficking, and Assembly of HIV (CHEETAH Center)

$4,797,029
Wesley Ian Sundquist · University Of Utah · P50 · FY2018 · GM

Human monoclonal antibodies for hantaviruses

$4,790,125
James E Crowe · Vanderbilt University Medical Center · U19 · FY2024 · AI

COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT

$4,789,670
University Of Alabama At Birmingham · P30 · FY2002 · CA

Center for the Structural Biology of Cellular Host Elements in Egress, Trafficking, and Assembly of HIV (CHEETAH Center)

$4,788,937
Wesley Ian Sundquist · University Of Utah · P50 · FY2021 · AI

GENERAL CLINICAL RESEARCH CENTER

$4,783,061
New York University School Of Medicine · M01 · FY2003 · RR

Mechanisms, modeling and therapies of retinal and macular neurodegeneration

$4,780,891
Anand Swaroop · National Eye Institute · ZIA · FY2025 · EY

Pharmacokinetics and Drug Metabolism

$4,779,148
Xin Xu · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR

Multi-Omic Biomarkers for Neuropathic Pain Secondary to Chemotherapy

$4,775,386
Daniel Rotroff · Cleveland Clinic Lerner Com-Cwru · R61 · FY2020 · NS

Clinical Research and Protocol Support Services

$4,774,744
William O'Donnell · National Eye Institute · ZID · FY2013 · EY

PET Radiopharmaceutical Sciences

$4,765,174
Victor W Pike · National Institute Of Mental Health · ZIA · FY2023 · MH

Clinical Research and Protocol Support Services

$4,761,363
William O'Donnell · National Eye Institute · ZID · FY2015 · EY

Yale Alzheimer Disease Research Center

$4,760,911
Stephen M Strittmatter · Yale University · P30 · FY2025 · AG

Therapeutic Editing to Lower PrP in Prion Disease

$4,751,225
Sonia Minikel Vallabh · Broad Institute, Inc. · U19 · FY2023 · NS

1/2 REPRIEVE Extension for Trial Completion

$4,747,407
Steven Kyle Grinspoon · Massachusetts General Hospital · UG3 · FY2024 · HL

Cold Spring Harbor Laboratory Cancer Research Center

$4,743,330
Gregory J Hannon · Cold Spring Harbor Laboratory · P01 · FY2010 · CA

Children's Oncology Group Pediatric Early Phase Clinical Trial Network

$4,739,780
Brenda J. Weigel · Children'S Hosp Of Philadelphia · UM1 · FY2018 · CA

Clinical Research and Protocol Support Services

$4,730,967
William O'Donnell · National Eye Institute · ZID · FY2014 · EY

Effects of inhibiting early inflammation in kidney transplant patients

$4,725,246
Peter Scott Heeger · Icahn School Of Medicine At Mount Sinai · U01 · FY2016 · AI